Premature Ejaculation
2-minute consultation reviewed by a UK clinician
We check your answers and recommend a suitable option
Plain packaging to your door, fast and confidential
Premature Ejaculation
Causes, types, diagnosis and UK treatment options — the definitive Access Doctor guide.
Key fact: Premature ejaculation (PE) is the most common male sexual dysfunction, affecting an estimated 20–30% of men across all age groups. Despite this, fewer than 25% of affected men ever seek treatment. PE is a recognised medical condition — not a personal failing — with effective, evidence-based prescription treatments available including dapoxetine (Priligy) and topical anaesthetic cream (EMLA).
What Is Premature Ejaculation?
Premature ejaculation is defined by the International Society for Sexual Medicine (ISSM) as a male sexual dysfunction characterised by three core features: ejaculation that always or nearly always occurs within approximately one minute of vaginal penetration; an inability to delay ejaculation on all or nearly all occasions; and negative personal consequences such as distress, bother, frustration or avoidance of sexual intimacy.
The condition is widely underreported and undertreated. Many men experience significant psychological distress, reduced sexual confidence, and relationship difficulties as a result of PE — yet the majority never discuss it with a healthcare professional. PE can affect men of all ages and is not related to a man's overall health, fitness or masculinity.
PE is distinct from occasional rapid ejaculation, which is part of normal variation in sexual function. The diagnosis is made when the pattern is persistent, causes distress, and meets clinical criteria — and a substantial number of men who believe they are too quick are within the normal range. Our guide to how long is normal sets out the measured figures and the three-part definition in full.
Types of Premature Ejaculation
Understanding which type of PE a man has guides treatment selection. The four recognised subtypes differ in their underlying mechanisms and response to treatment.
| Type | Definition | Key Features | Primary Drivers |
|---|---|---|---|
| Lifelong (primary) | Present since first sexual experience; consistent across all partners and situations | IELT typically <1–2 minutes; strong neurobiological basis | Altered serotonin (5-HT) receptor sensitivity; genetic predisposition |
| Acquired (secondary) | Develops after a period of normal ejaculatory function | Usually more variable; often has identifiable trigger | Erectile dysfunction; relationship stress; prostatitis; thyroid dysfunction; anxiety |
| Natural variable | Occasional early ejaculation in specific situations or with a new partner | Inconsistent; not present in all encounters | Normal variation; not a disorder; situational anxiety |
| Premature-like ejaculatory dysfunction | Subjective complaint of PE without meeting objective clinical criteria | IELT within normal range but perceived as too rapid | Unrealistic expectations; anxiety; relationship issues; benefits from psychosexual counselling |
Clinical note: Lifelong and acquired PE are the two subtypes that respond most clearly to pharmacological treatment. Natural variable PE and premature-like ejaculatory dysfunction are better addressed through psychosexual therapy, education and realistic expectation-setting.
Causes and Risk Factors
Neurobiological factors
The primary biological mechanism in lifelong PE is hypersensitivity of 5-HT2C receptors and hyposensitivity of 5-HT1A receptors, reducing the ejaculatory threshold. Penile hypersensitivity and a hyperactive ejaculatory reflex are also implicated. These mechanisms explain why SSRIs — which increase serotonergic activity — are the most effective pharmacological treatment.
Psychological factors
Performance anxiety, depression, stress, poor body image, early sexual experiences involving hurried ejaculation, and unrealistic expectations about sexual performance are among the most common contributors to acquired PE. Anxiety creates a feedback loop that perpetuates the condition — the mechanism is set out in premature ejaculation and anxiety.
Erectile dysfunction
ED and PE frequently co-exist. Men with ED may rush to ejaculate before losing their erection, creating a learned pattern of rapid ejaculation. Treating underlying ED often improves PE simultaneously, and the order of treatment matters — see when you have both. Both conditions should always be assessed together at clinical consultation.
Medical conditions
Prostatitis (particularly chronic pelvic pain syndrome), hyperthyroidism, and peripheral neuropathy have all been associated with acquired PE. A thorough medical history is essential when PE develops after a period of normal ejaculatory function to exclude a treatable underlying cause.
Relationship and lifestyle
Infrequent sexual activity, a new partner, relationship conflict and poor sexual communication can all precipitate or worsen PE. Excessive alcohol use acutely impairs ejaculatory control. Recreational drug use, particularly stimulants, can also affect ejaculatory function.
Genetic predisposition
Family studies suggest a genetic component to lifelong PE, likely mediated through serotonin transporter gene polymorphisms. Men with a first-degree relative with lifelong PE have a significantly higher risk of the condition themselves.
Symptoms and Psychological Impact
The primary symptom of PE is ejaculation that occurs sooner than desired. Beyond this, the condition carries a significant psychological burden that is frequently underestimated:
- Ejaculation within one to two minutes of penetration — or before penetration in severe cases
- Inability to voluntarily delay ejaculation despite wishing to do so
- Feelings of shame, embarrassment, inadequacy or loss of confidence
- Avoidance of sexual intimacy and new relationships
- Partner dissatisfaction and relationship strain
- Anxiety about sexual performance, creating a self-reinforcing cycle
- Reduced sexual satisfaction for both partners
- In some cases, secondary depression or generalised anxiety
Important: The psychological impact of PE is often as significant as the physical symptom. Men who avoid seeking help frequently experience worsening anxiety over time. Early treatment breaks the anxiety cycle and produces better long-term outcomes than delayed presentation. Difficulty raising it with a partner is one of the commonest reasons men delay — talking to your partner covers what partners actually report.
Diagnosis
PE is diagnosed clinically on the basis of a structured history. No laboratory tests are required for straightforward lifelong or psychogenic PE, though investigation is warranted when an underlying medical cause is suspected.
A prescriber will assess the following:
- Ejaculatory latency — how long after penetration ejaculation typically occurs
- Whether PE is lifelong or acquired, and whether it is situational or universal
- Degree of voluntary control and level of associated distress
- Presence of erectile dysfunction (which must be treated first or alongside PE)
- Relationship history, sexual history and psychological factors
- Medical history: prostatitis symptoms, thyroid symptoms, neurological conditions
- Current medications that may affect ejaculatory function
Where acquired PE develops suddenly in a man with previously normal function, assessment for prostatitis, thyroid dysfunction and erectile dysfunction is appropriate before starting treatment. This is a GP assessment rather than an online one, and may include urine testing and thyroid function tests where the history suggests them.
Treatment Options
Treatment for PE is selected based on subtype, severity, and the relative contribution of biological versus psychological factors. Most men benefit from a combination of approaches. NICE and the ISSM recommend pharmacological treatment, behavioural techniques and psychosexual therapy as the three pillars of management — with combined approaches producing the best outcomes.
Pharmacological Treatments
| Treatment | Mechanism | Dosing | Evidence |
|---|---|---|---|
| Dapoxetine (Priligy) | Short-acting SSRI; increases serotonergic activity at the ejaculatory reflex pathway | 30mg or 60mg taken 1–3 hours before sexual activity; maximum once in 24 hours | Increases IELT around 2.5–3× vs placebo; the only oral medicine licensed specifically for PE, in men aged 18–64; first-line oral treatment |
| EMLA cream (lidocaine/prilocaine) | Topical anaesthetic; reduces penile glans sensitivity and delays ejaculatory reflex | Applied to glans penis 20–30 minutes before sex; wiped off before intercourse to avoid partner numbness | Substantial increases in IELT reported in trials of topical anaesthetics; suitable where hypersensitivity is a component; minimal systemic absorption. Off-label for PE — see below |
| Fortacin (lidocaine/prilocaine spray) | Topical anaesthetic delivered as a metered spray to the glans | Applied a few minutes before intercourse | The topical product licensed specifically for primary PE in adult men; prescription-only |
| Daily SSRIs (off-licence) | Continuous serotonergic activity elevation raises ejaculatory threshold over time | Low-dose paroxetine, sertraline or fluoxetine taken daily; effect builds over 1–2 weeks | Strong ejaculation-delaying effect; prescribed off-licence by a GP or specialist rather than through an online consultation — see SSRIs and the daily option |
On licensing: dapoxetine is the only oral medicine licensed in the UK specifically for premature ejaculation, and Fortacin is the licensed topical product. Using EMLA cream for PE is an off-label use — widely done and supported by evidence, but outside the product's original licence as a skin anaesthetic. Daily SSRIs are prescribed off-licence. None of this makes these options improper; it changes who can prescribe them and how. EMLA cream for premature ejaculation covers the topical route in full.
Behavioural Techniques
| Technique | How It Works | Best For |
|---|---|---|
| Stop-start technique (Semans) | Sexual stimulation is paused when ejaculation feels imminent and resumed once arousal subsides; repeated to build ejaculatory control | All PE types; most effective when practised consistently over several weeks; can be self-administered or partner-assisted |
| Squeeze technique (Masters & Johnson) | Partner applies firm pressure to the coronal ridge of the glans when ejaculation is imminent, reducing arousal and delaying ejaculation | Acquired PE with a supportive partner; particularly effective when combined with medication; requires partner cooperation |
| Pelvic floor exercises | Strengthening the bulbocavernosus and ischiocavernosus muscles improves voluntary ejaculatory control | Lifelong and acquired PE; evidence-based adjunct; benefits accumulate over 12–16 weeks of regular practice |
Psychosexual Therapy
Psychosexual therapy addresses the psychological and relational dimensions of PE — performance anxiety, negative cognitions about sexual performance, communication difficulties and relationship dynamics. It is most effective when PE has a significant psychological component, and is typically delivered as a structured series of sessions either individually or with a partner. Combined with pharmacological treatment, psychosexual therapy produces superior outcomes to either approach alone.
Choosing the Right Treatment
| Situation | Recommended Approach |
|---|---|
| Lifelong PE, biological basis, no significant anxiety | Dapoxetine or a topical anaesthetic; add behavioural techniques; consider a daily SSRI via your GP if on-demand dosing is inconvenient |
| Acquired PE, co-existing erectile dysfunction | Treat ED first (PDE5 inhibitor); reassess PE — often improves significantly once ED is managed |
| Acquired PE, significant anxiety or relationship issues | Psychosexual therapy as primary approach; dapoxetine to support confidence while therapy progresses |
| Natural variable PE | Psychoeducation; behavioural techniques; reassurance that occasional rapid ejaculation is normal |
| PE with premature-like ejaculatory dysfunction | Psychosexual counselling; cognitive reframing; realistic expectation-setting; no pharmacological treatment indicated |
Combined treatment produces the best results: Clinical trials consistently show that dapoxetine combined with behavioural techniques produces significantly greater and more durable improvements in IELT and sexual satisfaction than either treatment alone. Men with significant anxiety particularly benefit from adding psychosexual therapy to their medication.
Get Premature Ejaculation Treatment Online
Access Doctor provides prescription treatment for premature ejaculation — including dapoxetine (Priligy) and EMLA cream — following a confidential online consultation with our GPhC-registered pharmacist independent prescribers. Discreet plain-packaging delivery. No GP appointment required.
View PE Treatments →When to Seek Help
You should seek a clinical assessment if:
- PE is causing you or your partner significant distress, frustration or avoidance of sex
- PE has developed suddenly after a period of normal ejaculatory function
- You also have difficulty achieving or maintaining an erection — both conditions should be assessed together
- PE is accompanied by pelvic pain, urinary symptoms or discomfort — which may suggest prostatitis
- You have tried behavioural techniques without satisfactory improvement
- PE is affecting your mental health, self-esteem or willingness to pursue intimate relationships
- You are using alcohol to manage PE — an unhelpful coping strategy with its own risks
Do not delay seeking help. PE is one of the most treatable sexual health conditions. Earlier treatment produces better outcomes, prevents anxiety from becoming entrenched, and avoids the relationship damage that untreated PE can cause over time.
Premature Ejaculation Guides
In-depth guides on premature ejaculation — what is normal, what causes it, and what each treatment route involves:
Frequently Asked Questions
What is premature ejaculation?
Premature ejaculation is a male sexual dysfunction characterised by ejaculation that occurs sooner than desired — typically within one to two minutes of penetration — with an inability to delay, and associated personal distress. It is the most common male sexual dysfunction, affecting 20–30% of men. It is a recognised medical condition, not a personal failing, and has effective prescription treatments.
What is the difference between lifelong and acquired premature ejaculation?
Lifelong (primary) PE has been present since a man's first sexual experiences and has a strong neurobiological basis, including altered serotonin receptor sensitivity. Acquired (secondary) PE develops after a period of normal ejaculatory function and is more commonly linked to erectile dysfunction, psychological factors, prostatitis, or thyroid dysfunction. Both are treatable, though the treatment approach differs.
What treatments are available for premature ejaculation in the UK?
The main prescription options are dapoxetine (Priligy) — an on-demand SSRI taken 1–3 hours before sex — and a topical anaesthetic such as EMLA cream, applied to reduce penile sensitivity. Fortacin, a lidocaine/prilocaine spray, is the topical product licensed specifically for PE. Behavioural techniques (stop-start, squeeze, pelvic floor exercises) and psychosexual therapy are also effective, particularly where psychological factors are significant. Combined approaches produce the best outcomes.
Is dapoxetine (Priligy) safe?
Dapoxetine is a prescription medicine licensed specifically for PE in men aged 18–64. It is generally well tolerated. Common side effects include nausea, dizziness, headache and diarrhoea. It must not be taken with other SSRIs, MAOIs, thioridazine, or certain recreational drugs. A clinical assessment is required before prescribing, including a blood pressure check, as dapoxetine can cause transient hypotension.
How effective is treatment for premature ejaculation?
Clinical trials show dapoxetine increases ejaculatory latency around 2.5–3 times compared with placebo. Topical anaesthetics can increase it further still. Combined treatment — medication plus behavioural therapy — produces greater and more durable improvements than either approach alone. Most men with PE respond well when treatment is started and maintained.
Is using EMLA cream for premature ejaculation off-label?
Yes. EMLA is licensed as a skin anaesthetic, and using it for premature ejaculation is an off-label use — widely done, supported by evidence, but outside the product's original licence. The topical product licensed specifically for premature ejaculation in the UK is Fortacin, a lidocaine/prilocaine spray. A prescriber can advise which is appropriate for you.
Can I get premature ejaculation treatment online in the UK?
Yes. Access Doctor provides prescription PE treatment — including dapoxetine (Priligy) and EMLA cream — following a confidential online consultation with our GPhC-registered pharmacist independent prescribers. No GP appointment required. Delivered in discreet plain packaging.
Prescription PE Treatment — Online Consultation
Access Doctor provides a discreet, confidential service for premature ejaculation. Complete a short online consultation reviewed by our GPhC-registered pharmacist independent prescribers — delivered to your door across the UK in plain packaging.
View All PE Treatments →References
- National Institute for Health and Care Excellence (NICE). Premature ejaculation: Clinical Knowledge Summary. cks.nice.org.uk/topics/premature-ejaculation
- NHS. Premature ejaculation. nhs.uk/conditions/premature-ejaculation
- Althof SE et al. An Update of the International Society of Sexual Medicine’s Guidelines for the Diagnosis and Treatment of Premature Ejaculation. Sexual Medicine. 2014;2(2):60–90.
- Electronic Medicines Compendium. Priligy film-coated tablets: Summary of Product Characteristics. medicines.org.uk/emc
- Electronic Medicines Compendium. Fortacin cutaneous spray solution: Summary of Product Characteristics. medicines.org.uk/emc
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Dapoxetine is the only oral medicine licensed in the UK specifically for premature ejaculation, and Fortacin the licensed topical product; EMLA cream and daily SSRIs are used for PE off-licence and require clinical assessment. Always consult a qualified healthcare professional for diagnosis and treatment. In a medical emergency, call 999.
